Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion.
Mlcochova P, Kemp SA, Dhar MS, Papa G, Meng B, Ferreira IATM, Datir R, Collier DA, Albecka A, Singh S, Pandey R, Brown J, Zhou J, Goonawardane N, Mishra S, Whittaker C, Mellan T, Marwal R, Datta M, Sengupta S, Ponnusamy K, Radhakrishnan VS, Abdullahi A, Charles O, Chattopadhyay P, Devi P, Caputo D, Peacock T, Wattal C, Goel N, Satwik A, Vaishya R, Agarwal M; Indian SARS-CoV-2 Genomics Consortium (INSACOG); Genotype to Phenotype Japan (G2P-Japan) Consortium; CITIID-NIHR BioResource COVID-19 Collaboration; Mavousian A, Lee JH, Bassi J, Silacci-Fegni C, Saliba C, Pinto D, Irie T, Yoshida I, Hamilton WL, Sato K, Bhatt S, Flaxman S, James LC, Corti D, Piccoli L, Barclay WS, Rakshit P, Agrawal A, Gupta RK. Mlcochova P, et al. Among authors: radhakrishnan vs. Nature. 2021 Nov;599(7883):114-119. doi: 10.1038/s41586-021-03944-y. Epub 2021 Sep 6. Nature. 2021. PMID: 34488225 Free PMC article.
Spatio-temporal dynamics of intra-host variability in SARS-CoV-2 genomes.
Pathak AK, Mishra GP, Uppili B, Walia S, Fatihi S, Abbas T, Banu S, Ghosh A, Kanampalliwar A, Jha A, Fatma S, Aggarwal S, Dhar MS, Marwal R, Radhakrishnan VS, Ponnusamy K, Kabra S, Rakshit P, Bhoyar RC, Jain A, Divakar MK, Imran M, Faruq M, Sowpati DT, Thukral L, Raghav SK, Mukerji M. Pathak AK, et al. Among authors: radhakrishnan vs. Nucleic Acids Res. 2022 Feb 22;50(3):1551-1561. doi: 10.1093/nar/gkab1297. Nucleic Acids Res. 2022. PMID: 35048970 Free PMC article.
Bispecific antibodies in indolent B-cell lymphomas.
Radhakrishnan VS, Davies AJ. Radhakrishnan VS, et al. Front Immunol. 2024 Jan 11;14:1295599. doi: 10.3389/fimmu.2023.1295599. eCollection 2023. Front Immunol. 2024. PMID: 38274793 Free PMC article. Review.
Antibody based therapies in Hodgkin lymphoma.
Radhakrishnan VS, Longley J, Johnson PWM. Radhakrishnan VS, et al. Cancer Treat Rev. 2024 Jan;122:102647. doi: 10.1016/j.ctrv.2023.102647. Epub 2023 Oct 28. Cancer Treat Rev. 2024. PMID: 37988820 Free article. Review.
Salvage Using Polatuzumab Vedotin Based Therapy in Relapsed Refractory Large B-Cell Lymphomas: Early Experience from a Real-World Middle-Income Setting Using Named-Patient Compassionate Access Program.
Radhakrishnan VS, Pincha R, Raina V, Garg JK, Nag A, Bhave SJ, Achari R, Dey D, Arun I, Lateef Z, Vinarkar SS, Parihar M, Sen S, Mishra DK, Chandy M, Nair R. Radhakrishnan VS, et al. Indian J Hematol Blood Transfus. 2022 Dec 25;39(4):1-5. doi: 10.1007/s12288-022-01619-w. Online ahead of print. Indian J Hematol Blood Transfus. 2022. PMID: 36590655 Free article.
Peripheral T-Cell Lymphoma, Hemophagocytic Lymphohistiocytosis, and XIAP Gene Mutations: Getting the Treatment Right!
Guntiboina VA, Radhakrishnan VS, Kumar J, Bhave SJ, Vinarkar S, Das J, Arun I, Mishra DK, Chandy M, Nair R. Guntiboina VA, et al. Among authors: radhakrishnan vs. Clin Lymphoma Myeloma Leuk. 2022 Oct;22(10):780-784. doi: 10.1016/j.clml.2022.05.005. Epub 2022 May 23. Clin Lymphoma Myeloma Leuk. 2022. PMID: 35697635 No abstract available.
30 results